Circulating Tumour DNA
Showing 1 - 25 of >10,000
The Role of Circulating Tumour DNA in Head and Neck Cancer
Recruiting
- Oropharyngeal Squamous Cell Carcinoma
- Human Papillomavirus (HPV)
-
Dundee, Dd2 1sg, United Kingdom
- +4 more
Sep 13, 2022
Testing Circulating Tumour DNA for Homologous Recombination Gene
Recruiting
- Circulating Tumor DNA
- Metastatic Prostate Cancer
- Blood sample
- Urine sample
-
Tours, FranceUniversity hospital
Sep 6, 2022
Stage II Colon Cancer, Stage III Colon Cancer Trial (5-Fluorouracil continuous infusion FOLFOXIRI schedule, 5-Fluorouracil bolus
Not yet recruiting
- Stage II Colon Cancer
- Stage III Colon Cancer
- 5-Fluorouracil continuous infusion FOLFOXIRI schedule
- +8 more
- (no location specified)
Aug 3, 2022
Simple Blood Test to Reduce Unnecessary Adverse Effects From
Not yet recruiting
- Pathological Response Rate, Circulating Tumour DNA
- MeD-seq
- (no location specified)
Sep 6, 2023
Circulating Tumour DNA and Urine Tumor DNA Detection of Minimal
Recruiting
- Muscle Invasive Upper Tract Urothelial Carcinoma
- Adjuvant chemotherapy
- adjuvant immunotherapy
-
Shanghai, Shanghai, ChinaRenji Hospital
Oct 30, 2022
Four Common Cancers Using the ctDNA Analysing Test
Recruiting
- Cancer, Lung
- +6 more
-
Hanoi, VietnamHanoi medical university
Nov 23, 2022
Neuroendocrine Tumors Trial in Belgium (Liquid biopsies, Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT))
Recruiting
- Neuroendocrine Tumors
- Liquid biopsies
- Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT)
-
Bornem, Antwerp, Belgium
- +7 more
Jun 1, 2022
Squamous Cell Carcinoma of the Oral Cavity Trial in Rouen (Circulating tumor DNA detection)
Not yet recruiting
- Squamous Cell Carcinoma of the Oral Cavity
- Circulating tumor DNA detection
-
Rouen, France
- +1 more
Jun 29, 2023
Neuroendocrine Tumors Trial in Edegem, Sint-Niklaas, Nicosia (Liquid biopsies, Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT))
Recruiting
- Neuroendocrine Tumors
- Liquid biopsies
- Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT)
-
Edegem, Antwerp, Belgium
- +2 more
Feb 24, 2022
Melanoma (Skin), Melanoma, Stage II Trial in Manchester (Nivolumab 10 MG/ML)
Recruiting
- Melanoma (Skin)
- Melanoma, Stage II
- Nivolumab 10 MG/ML
-
Manchester, Greater Manchester, United KingdomThe Christie NHS Foundation Trust
Nov 11, 2021
Circulating Tumour DNA Testing in Assessing for Alterations of
Recruiting
- Colorectal Cancer
-
Singapore, SingaporeNational University Hospital
Sep 28, 2021
Circulating Tumour DNA asPrognostic and Predictive Marker in
Recruiting
- Colorectal Cancer
-
Oslo, Norway
- +7 more
Apr 13, 2022
Treatment in Cancers of Head and Neck
Recruiting
- Head and Neck Cancer
- Circulating tumour DNA dynamics
-
London, United KingdomThe Royal Marsden Hospital
Dec 6, 2022
ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Christchurch, London, Oxford (Palbociclib 125Mg Tab, Fulvestrant
Recruiting
- ER+ Breast Cancer
- HER2-negative Breast Cancer
- Palbociclib 125Mg Tab
- +5 more
-
Christchurch, United Kingdom
- +3 more
May 19, 2022
CIrculating Tumour DNA in Lung Cancer: Optimizing Sensitivity
Completed
- Lung Neoplasms
- +3 more
- Circulating tumour DNA (ctDNA)
-
London, Ontario, CanadaLondon Regional Cancer Program
Feb 17, 2021
Residual Disease & Response to Adjuvant Chemotherapy in Stage
Recruiting
- Ovarian Cancer
- Circulating tumour DNA testing
-
Baltimore, Maryland
- +6 more
Nov 2, 2020
Colon Cancer Stage II Trial in Dresden (Capecitabine)
Recruiting
- Colon Cancer Stage II
-
Dresden, Sachsen, GermanyUniversitaetsklinikum Carl Gustav Carus, Medizinische Klinik
Aug 5, 2020
Lung Tumors, EGFR Gene Mutation Trial in Hwasun (Afatinib)
Completed
- Lung Neoplasms
- EGFR Gene Mutation
-
Hwasun, Jeonnam, Korea, Republic ofChonnam National University Hwasun Hospital
Aug 1, 2021
From Patients With High Grade Gliomas
Recruiting
- High Grade Glioma
- Radiotherapy as per standard of care
-
Toronto, Ontario, CanadaUniversity Health Network
Jun 21, 2023
Melanoma Trial in Manchester (ctDNA analysis)
Recruiting
- Melanoma
- ctDNA analysis
-
Manchester, United KingdomThe Christie NHS Foundation Trust
Jul 30, 2020
Dynamics of Clonal Evolution Leading to Recurrence in Prostate
Recruiting
- Prostate Cancer Recurrent
-
Sutton, Surrey, United KingdomRoyal Marsden Hospital
Dec 22, 2020
Clinical Significance of Circulating Tumour Cells in Resectable
Completed
- Non Small Cell Lung Cancer
- Circulating Tumor Cell
- Device for CTC/DTC detection
-
Olomouc, Česká Republika, CzechiaUniversity Hospital Olomouc
Nov 9, 2022
Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker
Recruiting
- Ovarian Neoplasms
- +2 more
-
Aarhus, DenmarkDepartment of Gynaecology and Obstetrics, Aarhus University Hosp
Mar 9, 2023
Circulating Tumor DNA (ctDNA) in Late-stage Breast Cancer
Completed
- Metastatic Breast Cancer
- +2 more
- ctDNA testing
- (no location specified)
Jun 16, 2022
Circulating Tumor DNA Sequencing in Peripheral T-cell Lymphomas
Not yet recruiting
- Peripheral T Cell Lymphoma
- circulating tumoral DNA detection
-
Rouen, FranceCentre Henri Becquerel
Oct 13, 2023